| Product Code: ETC13245085 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Artemisinin Market was valued at USD 2.9 Billion in 2024 and is expected to reach USD 4.3 Billion by 2031, growing at a compound annual growth rate of 8.77% during the forecast period (2025-2031).
The global artemisinin market is experiencing growth due to increasing demand for artemisinin-based combination therapies (ACTs) to combat malaria. Artemisinin, derived from the sweet wormwood plant, is known for its effectiveness in treating malaria, particularly in regions where the disease is prevalent. Factors driving market growth include rising investments in healthcare infrastructure, government initiatives to control malaria, and growing awareness about the benefits of artemisinin-based treatments. The Asia-Pacific region dominates the market in terms of production and consumption, with key players focusing on expanding their presence in emerging markets. However, challenges such as supply chain disruptions, fluctuating raw material prices, and counterfeit drugs remain significant concerns for market players. Overall, the global artemisinin market is poised for continued growth driven by the need for effective malaria treatment solutions.
The global artemisinin market is witnessing a surge in demand due to its use in the production of artemisinin-based combination therapies (ACTs) for the treatment of malaria. As the prevalence of malaria continues to be a major health concern in many regions, there is a growing emphasis on the adoption of ACTs as an effective treatment option. Additionally, the increasing awareness about the efficacy of artemisinin in combating drug-resistant strains of malaria is driving market growth. Opportunities in the market include the development of new formulations and dosage forms of artemisinin, as well as the expansion of production capacities to meet the rising demand. Collaborations between pharmaceutical companies and research institutions for the development of innovative artemisinin-based products also present promising avenues for market players to explore.
The Global Artemisinin Market faces challenges such as fluctuating prices due to supply chain disruptions, limited availability of raw materials, regulatory hurdles in some regions, and the threat of counterfeit products impacting market integrity. The dependence on a few key producing countries for Artemisinin cultivation also poses risks related to geopolitical instability and climate change. Additionally, the growing demand for Artemisinin-based drugs to combat malaria alongside the need for sustainable production practices further complicates the market landscape. Navigating these challenges requires strategic partnerships along the supply chain, investment in research and development for alternative sourcing methods, and stringent quality control measures to ensure the efficacy and safety of Artemisinin derivatives in pharmaceutical applications.
The Global Artemisinin Market is primarily driven by the increasing prevalence of malaria cases worldwide, particularly in regions with high mosquito populations. The growing demand for artemisinin-based combination therapies (ACTs) as the most effective treatment for malaria is also fueling market growth. Additionally, government initiatives and non-profit organizations focusing on malaria eradication programs are creating a favorable market environment for artemisinin products. Furthermore, the rising investments in research and development to develop novel drug formulations using artemisinin derivatives for treating other diseases such as cancer and autoimmune disorders are expected to drive market expansion. The sustainability and scalability of artemisinin production through innovative cultivation techniques and genetic engineering are further contributing to the market`s growth trajectory.
Government policies related to the Global Artemisinin Market typically focus on promoting sustainable cultivation practices, ensuring quality control measures, and preventing counterfeit products in order to safeguard public health and support the growth of the pharmaceutical industry. Regulatory bodies such as the World Health Organization (WHO) and various national health agencies set guidelines for the production, distribution, and use of artemisinin-based drugs to combat malaria effectively. Additionally, governments may offer incentives or subsidies to encourage farmers to cultivate Artemisia annua, the plant from which artemisinin is derived, in sufficient quantities to meet global demand. Strict enforcement of intellectual property rights and international trade agreements also play a significant role in regulating the market and ensuring fair competition among pharmaceutical companies producing artemisinin-based medications.
The Global Artemisinin Market is expected to experience steady growth in the coming years due to the increasing demand for artemisinin-based combination therapies (ACTs) in the treatment of malaria, the leading cause of death in many tropical and subtropical regions. Factors such as rising awareness about the effectiveness of artemisinin in treating drug-resistant strains of malaria, ongoing research and development activities to enhance artemisinin production, and government initiatives to control malaria transmission are likely to drive market growth. Additionally, the growing focus on sustainable and environmentally friendly artemisinin cultivation practices is anticipated to further boost the market. However, challenges such as fluctuating artemisinin prices, regulatory hurdles, and supply chain disruptions may hinder market expansion to some extent. Overall, the Global Artemisinin Market is poised for a positive outlook in the foreseeable future.
In the Global Artemisinin Market, Asia holds a dominant position due to the presence of key producing countries such as China and Vietnam. These countries account for a significant portion of the world`s artemisinin supply. North America and Europe are major consumers of artemisinin-based products, driven by the rising demand for anti-malarial drugs. The Middle East and Africa region is also a key market for artemisinin, given the high prevalence of malaria in certain countries. In Latin America, the market for artemisinin is growing steadily, supported by increasing awareness about the efficacy of artemisinin-based drugs in treating malaria. Overall, the global artemisinin market is characterized by regional variations in production, consumption, and regulatory frameworks.
Global Artemisinin Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Artemisinin Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Artemisinin Market Revenues & Volume, 2021 & 2031F |
3.3 Global Artemisinin Market - Industry Life Cycle |
3.4 Global Artemisinin Market - Porter's Five Forces |
3.5 Global Artemisinin Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Artemisinin Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Global Artemisinin Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Global Artemisinin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Artemisinin Market Trends |
6 Global Artemisinin Market, 2021 - 2031 |
6.1 Global Artemisinin Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Artemisinin Market, Revenues & Volume, By Extraction from Artemisia Annua, 2021 - 2031 |
6.1.3 Global Artemisinin Market, Revenues & Volume, By Semisynthetic Artemisinin, 2021 - 2031 |
6.2 Global Artemisinin Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Artemisinin Market, Revenues & Volume, By Antimalarial Injections, 2021 - 2031 |
6.2.3 Global Artemisinin Market, Revenues & Volume, By Antimalarial Tablets, 2021 - 2031 |
6.3.1 Overview & Analysis |
7 North America Artemisinin Market, Overview & Analysis |
7.1 North America Artemisinin Market Revenues & Volume, 2021 - 2031 |
7.2 North America Artemisinin Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Artemisinin Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Artemisinin Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Artemisinin Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Artemisinin Market, Revenues & Volume, By Type, 2021 - 2031 |
7.4 North America Artemisinin Market, Revenues & Volume, By Application, 2021 - 2031 |
8 Latin America (LATAM) Artemisinin Market, Overview & Analysis |
8.1 Latin America (LATAM) Artemisinin Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Artemisinin Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Artemisinin Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Artemisinin Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Artemisinin Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Artemisinin Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Artemisinin Market, Revenues & Volume, By Type, 2021 - 2031 |
8.4 Latin America (LATAM) Artemisinin Market, Revenues & Volume, By Application, 2021 - 2031 |
9 Asia Artemisinin Market, Overview & Analysis |
9.1 Asia Artemisinin Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Artemisinin Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Artemisinin Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Artemisinin Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Artemisinin Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Artemisinin Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Artemisinin Market, Revenues & Volume, By Type, 2021 - 2031 |
9.4 Asia Artemisinin Market, Revenues & Volume, By Application, 2021 - 2031 |
10 Africa Artemisinin Market, Overview & Analysis |
10.1 Africa Artemisinin Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Artemisinin Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Artemisinin Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Artemisinin Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Artemisinin Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Artemisinin Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Artemisinin Market, Revenues & Volume, By Type, 2021 - 2031 |
10.4 Africa Artemisinin Market, Revenues & Volume, By Application, 2021 - 2031 |
11 Europe Artemisinin Market, Overview & Analysis |
11.1 Europe Artemisinin Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Artemisinin Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Artemisinin Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Artemisinin Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Artemisinin Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Artemisinin Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Artemisinin Market, Revenues & Volume, By Type, 2021 - 2031 |
11.4 Europe Artemisinin Market, Revenues & Volume, By Application, 2021 - 2031 |
12 Middle East Artemisinin Market, Overview & Analysis |
12.1 Middle East Artemisinin Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Artemisinin Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Artemisinin Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Artemisinin Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Artemisinin Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Artemisinin Market, Revenues & Volume, By Type, 2021 - 2031 |
12.4 Middle East Artemisinin Market, Revenues & Volume, By Application, 2021 - 2031 |
13 Global Artemisinin Market Key Performance Indicators |
14 Global Artemisinin Market - Export/Import By Countries Assessment |
15 Global Artemisinin Market - Opportunity Assessment |
15.1 Global Artemisinin Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Artemisinin Market Opportunity Assessment, By Type, 2021 & 2031F |
15.3 Global Artemisinin Market Opportunity Assessment, By Application, 2021 & 2031F |
16 Global Artemisinin Market - Competitive Landscape |
16.1 Global Artemisinin Market Revenue Share, By Companies, 2024 |
16.2 Global Artemisinin Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |